Octreotide LAR for severe obscure-overt gastrointestinal haemorrhage in high-risk patients on anticoagulation therapy [11]

Gut

Volumn 56, Issue 3, 2007, Pages 447-

  Molina Infante, J ^a   Perez Gallardo, B ^a   Gonzalez Garcia, G ^a   Fernandez Bermejo, M ^a   Mateos Rodriguez, J M ^a   Robledo Andres, P ^a  

^a HOSPITAL SAN PEDRO DE ALCÁNTARA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HEMOGLOBIN; OCTREOTIDE; ANTICOAGULANT AGENT; GASTROINTESTINAL AGENT;

ABDOMINAL RADIOGRAPHY; ABSENCE OF SIDE EFFECTS; AGED; ANAMNESIS; ANGIODYSPLASIA; ANTICOAGULANT THERAPY; CARDIOVASCULAR DISEASE; CAROTID ARTERY OBSTRUCTION; CASE REPORT; CLINICAL FEATURE; DISEASE EXACERBATION; DRUG SAFETY; DRUG TOLERABILITY; ENDOSCOPY; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HIGH RISK PATIENT; HUMAN; JEJUNUM DISEASE; LETTER; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; DELAYED RELEASE FORMULATION; NOTE; RECURRENT DISEASE;

AGED; ANTICOAGULANTS; DELAYED-ACTION PREPARATIONS; GASTROINTESTINAL AGENTS; GASTROINTESTINAL HEMORRHAGE; HUMANS; MALE; OCTREOTIDE; RECURRENCE;

EID: 34047098284     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2006.113878     Document Type: Letter

References (8)

1. Lai LH, Wong GL, Chow DK, et al. Long term follow up of patients with obscure gastrointestinal bleeding after negative capsule endoscopy. Am J Gastroenterol 2006;101:1224-9.
2. Zuckerman GR, Prakash C, Ashkin MP, et al. AGA technical review: evaluation and management of occult and obscure gastrointestinal bleeding. Gastroenterology 2000;118:20.
3. Junquera F, Feu F, Papo M, et al. A multicenter, randomized, clinical trial of hormonal therapy in the prevention of rebleeding from gastrointestinal angiodysplasia. Gastroenterology 2001;121:1073-9.
4. Hodgson H. Hormonal therapy for gastrointestinal angiodysplasia. Lancet 2002;359:1630-1.
5. Nardone G, Rocco A, Balzano T, et al. The efficacy of octreotide therapy in chronic bleeding due to vascular abnormalities of the gastrointestinal tract. Aliment Pharmacol Ther 1999;13:1429-36.
6. Bosch J, Abraldes JG. Variceal bleding: pharmacological therapy. Dig Dis Sci 2005;23:18-29.
7. Orsi P, Guatti-Zuliani C, Okolicsanyi L. Long-acting octreotide is effective in controlling rebleeding angiodysplasia of the gastrointestinal tract. Dig Liver Dis 2001;33:330-4.
8. Tamagno G, Mioni R, De Carlo E, et al. Effects of a somatostatin analogue in occult gastrointestinal bleeding: a case report. Dig Liver Dis 2004;36:843-6.